WAVE Life Sciences (WVE) Prices 8.33M Share Offering at $12/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
After-Hours Stock Movers 09/22: (NKE) (FL) (TSLA) Higher; (WVE) (SFIX) (ACB) Lower (more...)
September 22, 2020 5:57 PM EDTAfter-Hours Stock Movers
Wave Life Sciences Ltd. (Nasdaq: WVE) 24.6% LOWER; commenced an underwritten public offering of its ordinary shares. In connection with the offering, Wave intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares sold in the public offering on the same terms and conditions. All of the shares in the offering will be sold by Wave Life Sciences.
Stitch Fix (NASDAQ: SFIX) 16.5% LOWER; reported Q4 EPS of ($0.44),... More
WAVE Life Sciences (WVE) Announces Proposed Public Offering of Ordinary Shares
September 22, 2020 4:01 PM EDTWave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that it has commenced an underwritten public offering of its ordinary shares. In connection with the offering, Wave intends to... More
WAVE Life Sciences (WVE) PT Raised to $27 at Truist Securities
September 22, 2020 7:27 AM EDTTruist Securities raised its price target on WAVE Life Sciences (NASDAQ: WVE) to $27.00 (from $20.00) while maintaining a rating.... More

